Discription of Jakavi 20mg
Jakavi 20Mg Tablet is a type of kinase inhibitor used to treat bone marrow problems like myelofibriosis and polycythemia vera in case there is an inadequate response or intolerance towards hydroxyurea. Its mechanism involves blocking substances involved in myelofibriosis, like JAK1 and JAK2.
How to use Jakavi Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. How take Jakavi 20mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Jakavi Tablet works
Jakavi 20Mg Tablet is an anti-cancer medication. How work jakavi 20mg -It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
In addition to its intended side effect of Jakavi 20Mg Tablet may cause some unwanted effects too. In such cases, you must seek medical attention immediately. This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.
Reduced blood platelets
Who should NOT take Jakavi 20Mg?
Do not take this medication if you:
are allergic to ruxolitinib or any ingredients of the medication
have a history of an illness called progressive multifocal leukoencephalopathy
Expert advice for Jakavi 20Mg
- You will be recommended frequent blood tests (every 2 to 4 weeks) and your doctor can change the dosage based on your test reports.
Tell your doctor if you have or have had any infections such as tuberculosis (TB), hepatitis etc. or any disorders of the kidney, liver or any form of skin cancers.
Do not take Jakavi 20Mg before a dialysis treatment.
Take necessary precautions as ruxolitinib may reduce the number of clot-forming cells (platelets) in your blood and the ability of your body to fight infection.
Seek immediate medical attention if you experience unexplained bruising, sudden bleeding, unusual tiredness, difficulty in breathing, pale skin, frequent infections, fever, chills, prolonged coughing, increased sweating at night, sudden weight loss, loss of balance, difficulties in walking/coordination, speaking difficulties, clumsiness, difficulty in thinking, blurring of vision, weakness on one side of body, painful skin rashes with blisters or any unusual skin changes.
Do not give ruxolitinib to children aged below 18 years.
Do not drive or operate machinery after using Jakavi 20Mg as it may cause dizziness.
Tell your doctor if you are or planning to become pregnant or breastfeeding.
Do not take Jakavi 20Mg if allergic to ruxolitinib or any of its ingredients.
Key highlights of Jakavi 20Mg Tablet
Is It safe with alcohol?
Interaction with alcohol is unknown. Please consult your doctor.
Are there any pregnancy warnings?
Jakavi 20Mg tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Are there any breast-feeding warnings?
Jakavi 20Mg tablet is probably unsafe to use during breastfeeding. Please consult your doctor.
Is it safe to drive while on this medicine?
Does this affect kidney function?
Caution should be used in patients with renal impairment.
Does this affect liver function?
There is no data available. Please consult doctor before consuming the drug.
For More information to visit our Site Medypharma.com